GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eyebright Medical Technology (Beijing) Co Ltd (SHSE:688050) » Definitions » Debt-to-Asset

Eyebright Medical Technology (Beijing) Co (SHSE:688050) Debt-to-Asset : 0.12 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Eyebright Medical Technology (Beijing) Co Debt-to-Asset?

Eyebright Medical Technology (Beijing) Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥128 Mil. Eyebright Medical Technology (Beijing) Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥249 Mil. Eyebright Medical Technology (Beijing) Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ¥3,035 Mil. Eyebright Medical Technology (Beijing) Co's debt to asset for the quarter that ended in Mar. 2024 was 0.12.


Eyebright Medical Technology (Beijing) Co Debt-to-Asset Historical Data

The historical data trend for Eyebright Medical Technology (Beijing) Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eyebright Medical Technology (Beijing) Co Debt-to-Asset Chart

Eyebright Medical Technology (Beijing) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial - - 0.08 0.07 0.13

Eyebright Medical Technology (Beijing) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.07 0.07 0.13 0.12

Competitive Comparison of Eyebright Medical Technology (Beijing) Co's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, Eyebright Medical Technology (Beijing) Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eyebright Medical Technology (Beijing) Co's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eyebright Medical Technology (Beijing) Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Eyebright Medical Technology (Beijing) Co's Debt-to-Asset falls into.



Eyebright Medical Technology (Beijing) Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Eyebright Medical Technology (Beijing) Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(117.941 + 272.385) / 3061.787
=0.13

Eyebright Medical Technology (Beijing) Co's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(127.849 + 248.839) / 3035.082
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eyebright Medical Technology (Beijing) Co  (SHSE:688050) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Eyebright Medical Technology (Beijing) Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Eyebright Medical Technology (Beijing) Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Eyebright Medical Technology (Beijing) Co (SHSE:688050) Business Description

Traded in Other Exchanges
N/A
Address
No. 9, Xingchang Road, Science and Technology Park, Changping District, Beijing, CHN, 102200
Eyebright Medical Technology (Beijing) Co Ltd is engaged in research and development, production, sales and related services of ophthalmic medical devices. The company's product range includes Intraocular Lens; IOL Delivery System; Ophthalmic Instruments; Other Products; Literature; and Expert Interview.

Eyebright Medical Technology (Beijing) Co (SHSE:688050) Headlines

No Headlines